Immunotherapy of prostatic cancer with Bacillus Calmette-Guérin and purified protein derivative. Preliminary results.
D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000368:Aged; D000917:Antibody Formation; D001500:BCG Vaccine; D001797:Blood Protein Electrophoresis; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007167:Immunotherapy; D007267:Injections; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D008722:Methods; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D012882:Skin Tests; D014373:Tuberculin / Q000627:therapeutic use*
D001500:BCG Vaccine; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D014373:Tuberculin